Navigation Links
eMetagens infectious disease technology licensed by WARF

MADISON - eMetagen announced Monday it has completed a license agreement with the Wisconsin Alumni Research Foundation to commercialize technology developed by Robert Goodman and collaborators at the University of Wisconsin-Madison over the past nine years.

Founded by Goodman, a UW profes......

Full article >>> 8,520 STTR Grant from the National Institutes of Health in March. The grant will fund research to find novel anti-bioweapon compounds in eMetagens natural product libraries. The company will begin operations at the McAllen T.E.C. Incubator on May 15th, 2004.

As a winner of the UW Business Schools Burrill Competition in 2001, Copaescu reflected on how the experience affected her work for ......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 05/05/04


Related biology technology :

1. Medical College receives $377K to study brain disease
2. Stem cells produce anti-disease protein in brain experiment
3. Neurognostics pushes early prediction of brain disease
4. ZyStor receives first funding and buys theraputics for rare diseases
5. Thompsons HHS legacy will include efforts to combat disease in Africa
6. Predictive medicine: Genes indicate diseases before symptoms do
7. FDA approves Bone Cares Hectorol for treatment of kidney disease
8. Symposium examines the effect of race on genetics and disease
9. HotMasterAn innovative Hot Start/Cold Stop technology for better PCR* results
10. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
11. GOP, Dems split over funding of state technology projects
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/4/2016)... 4, 2016 - New FDA action date of ... New FDA action date of July 22, 2016   ... 22, 2016   - Lifitegrast ... decade indicated for the treatment of signs and symptoms of dry ... the potential to be the only product approved in the U.S. in the past decade ...
(Date:2/4/2016)... , Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... commercializing its flagship CytoSorb® blood filter to treat ... around the world, announced that CEO Dr. ... the Source Capital Group,s 2016 Disruptive Growth & ... the company.  Conference Presentation Details: ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... China , today announced that the ... February 4, 2016 a preliminary non-binding proposal letter, dated ... V-Ming ( Shanghai ) Investment Holdings Co., ... Shenzhen ) Fund Management Co., Ltd., Beijing ...
(Date:2/3/2016)... , Feb. 3, 2016  Discovery Laboratories, Inc. ... on developing aerosolized KL4 surfactant therapies for respiratory ... has approved an inducement award as a component ... its newly appointed President and Chief Executive Officer.  ... Committee on February 1, 2016 and granted as ...
Breaking Biology Technology:
(Date:1/21/2016)... India , January 21, 2016 ... According to a new market research report "Emotion Detection ... and Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020", published by ... is expected to reach USD 22.65 Billion by ...
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., a ... simplifies the use and access of ubiquitous on-premise ... partnership with American Cyber.  ... experience leading transformational C4ISR and Cyber initiatives in ... the latest proven technology solutions," said Steve ...
(Date:1/11/2016)... Jan. 11, 2016 Synaptics Incorporated (NASDAQ: ... today announced that its ClearPad ® TouchView ™ ... won two separate categories in the 8 th ... Best Technology Breakthrough. The Synaptics ® TDDI solution ... supply chain, thinner devices, brighter displays and borderless designs. ...
Breaking Biology News(10 mins):